
Nolato (OM:NOLA B) is back in focus after its latest quarterly report, where higher sales coincided with lower net income and earnings per share compared with the same period last year.
The mixed earnings picture seems to line up with how the Nolato share price has behaved this year. The stock has slipped about 11% on a year to date share price basis to SEK53.1, even though the 3 year total shareholder return is positive while the 5 year total shareholder return is still sharply lower.
Scan beyond Nolato and spot other manufacturers with improving fundamentals and compressed valuations using our hand picked 195 high quality undervalued stocks.
Nolato looks like a solid specialist manufacturer on the surface, yet the share price has fallen and earnings have softened. Is this still a strong business simply marked down, or is the current valuation fair for that reality?
Nolato’s analyst consensus Narrative on Simply Wall St currently estimates fair value at SEK66.5 per share, compared with the latest close of SEK53.1. That gap rests on specific expectations for mix, margins and capital intensity, not on vague optimism.
Recent and ongoing capacity expansions in Hungary, Poland, Malaysia, Mexico and the U.S., including the GLP 1 drug delivery program that has moved from validation into commercial volumes with a planned ramp through 2029, are laying the groundwork for multi year volume growth and increasing operating leverage in both revenue and earnings.
See why 5 investors see Nolato as 20% undervalued.
Result: Fair Value of SEK66.5 (UNDERVALUED)
Still, the Nolato story can unravel if raw material costs bite harder than expected or if uneven demand in areas like automotive and hygiene drags on volumes.
Find out about the key risks to this Nolato narrative.
If the mixed messages on Nolato leave you unsure, act while the details are fresh. Weigh both sides of the story using the 2 key rewards and 1 important warning sign.
If Nolato has sharpened your appetite for quality opportunities, do not stop here. Put fresh ideas on your radar before the market prices them in.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com